Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03587662
Title	Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	M.D. Anderson Cancer Center
Indications	collecting duct carcinoma kidney cancer kidney rhabdoid cancer
Therapies	Gemcitabine + Ixazomib Doxorubicin + Gemcitabine + Ixazomib
Age Groups:	senior \| child \| adult
Covered Countries	USA